329 filings
8-K
BSTC
Biospecifics Technologies Corp.
2 Dec 20
BioSpecifics Announces Completion of Acquisition by Endo Pharmaceuticals
9:22am
8-K
BSTC
Biospecifics Technologies Corp.
9 Nov 20
BioSpecifics Reports Third Quarter 2020 Financial and Operating Results
8:14am
8-K
BSTC
Biospecifics Technologies Corp.
19 Oct 20
BioSpecifics to be Acquired by Endo Pharmaceuticals
9:23am
8-K
BSTC
Biospecifics Technologies Corp.
14 Sep 20
Regulation FD Disclosure
7:32am
8-K
BSTC
Biospecifics Technologies Corp.
31 Aug 20
Entry into a Material Definitive Agreement
5:02pm
8-K
4dvrj3 8c
11 Aug 20
Regulation FD Disclosure
8:01am
8-K
s1xqacny9 2iro132
10 Aug 20
BioSpecifics Reports Second Quarter 2020 Financial and Operating Results
8:00am
8-K
w3ojbax2f 34sd5pjfll
20 Jul 20
BioSpecifics Appoints Alex Monteith as Chief Business Officer
7:25am
8-K
4dlek0vqk
14 Jul 20
Regulation FD Disclosure
4:15pm
8-K
adi uczcqq4b
15 Jun 20
Amendments to Articles of Incorporation or Bylaws
8:01am
8-K
nk79bn
12 Jun 20
Regulation FD Disclosure
6:27am
8-K
2sciybmpu3obs6qw
8 Jun 20
Departure of Directors or Certain Officers
11:22am
8-K
971az5v3c
11 May 20
BioSpecifics Reports First Quarter 2020 Financial and Operating Results
8:36am
8-K
af0fxldceg xwj
11 May 20
BioSpecifics Names Joseph Truitt as Permanent Chief Executive Officer
8:32am
8-K
11z0 04nhcn1s0y73nau
10 Apr 20
Entry into a Material Definitive Agreement
4:35pm
8-K
zp3miy1avulmeenot
9 Apr 20
BioSpecifics Appoints Joseph Truitt as Interim Chief Executive Officer
8:11am
8-K
3ercuk
23 Mar 20
Building a next-generation company on the foundation of our collagenase-based therapies MARCH 2020
3:50pm
8-K
7ghl1js 7fqn
16 Mar 20
BioSpecifics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
4:14pm
8-K
cazj4icwpsdf1
13 Jan 20
Regulation FD Disclosure
6:37am
8-K
xr9ory3 gj37kl
7 Jan 20
Termination of a Material Definitive Agreement
5:15pm